Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase: results from a single-group, phase 2, open-label study
Nom du journal : Ann Intern Med
Année : 2018
Volume : 168
Page de départ : 461
Page de fin : 470